-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Intellipharmaceutics International Inc. annual/quarterly Revenues history and growth rate from Q1 2016 to Q2 2017.
- Intellipharmaceutics International Inc. Revenues for the quarter ending May 31, 2017 was CA$2M, a 260% increase year-over-year.
- Intellipharmaceutics International Inc. annual Revenues for 2018 was CA$1.71M, a 68.9% decline from 2017.
- Intellipharmaceutics International Inc. annual Revenues for 2017 was CA$5.5M, a 145% increase from 2016.
- Intellipharmaceutics International Inc. annual Revenues for 2016 was CA$2.25M, a 45.1% decline from 2015.
Revenues, Quarterly (CAD)
Revenues, YoY Quarterly Growth (%)